TY - JOUR
T1 - Small-bowel capsule endoscopy in patients with Meckel's diverticulum
T2 - clinical features, diagnostic workup, and findings. A European multicenter I-CARE study
AU - Baltes, Peter
AU - Dray, Xavier
AU - Riccioni, Maria Elena
AU - Pérez-Cuadrado-Robles, Enrique
AU - Fedorov, Evgeny
AU - Wiedbrauck, Felix
AU - Chetcuti Zammit, Stefania
AU - Cadoni, Sergio
AU - Bruno, Mauro
AU - Rondonotti, Emanuele
AU - Johansson, Gabriele Wurm
AU - Mussetto, Alessandro
AU - Beaumont, Hanneke
AU - Perrod, Guillaume
AU - McNamara, Deirdre
AU - Plevris, John
AU - Spada, Cristiano
AU - Pinho, Rolando
AU - Rosa, Bruno
AU - Hervas, Nerea
AU - Leenhardt, Romain
AU - Marmo, Clelia
AU - Esteban-Delgado, Pilar
AU - Ivanova, Ekaterina
AU - Keuchel, Martin
AU - of the International Capsule Endoscopy Research (I-CARE) Meckel study group
AU - Carretero, Cristina
AU - Tontini, Gian Eugenio
AU - Toth, Ervin
AU - Nemeth, Artur
AU - Sidhu, Reena
AU - Koulaouzidis, Anastasios
AU - Eliakim, Abraham
AU - Pennazio, Marco
AU - Tikhomirova, Ekaterina
AU - Zebski, Hubert
AU - Wulfert, Chris-Henrik
AU - Stachow, Florentin
AU - Janssen, Garrelt
AU - Carretero, C.
AU - Tontini, E.
AU - Toth, E.
N1 - Funding Information:
Disclosure: The following authors disclosed financial relationships: P. Baltes: Speaker fees from Medtronic; study support from Ankon. X. Dray: Speaker fees from MSD, Pfizer, Medtronic, Bouchara Recordati, FUJIFILM, Alfasigma, and Norgine; consultant for Alfasigma, Norgine, and PENTAX; cofounder of and shareholder in Augmented Endoscopy; training and travel support from Ankon. C. Spada: Consultant fees from Medtronic; advisory board and speaker fees from Norgine; speaker fees from Pentax; study and travel support fees from Ankon; speaker and advisory board fees from Olympus. H. Beaumont: Speaker fees from Medtronic. E. Rondonotti: Speaker honoraria from FUJIFILM; member of FUJIFILM expert group; and Medtronic Co. consulting agreement. J. Plevris: Lecture honoraria from Jinshan group; and research support from FUJIFILM. R. Leenhardt: Cofounder and shareholder of Augmented Endoscopy; and lecturer for AbbVie. M. Keuchel: Speaker and consultant fees from Medtronic; speaker fees from Olympus; and study support from Ankon. G. Johansson: speaker fees from Medtronic. D. McNamara: Investigator led grant from Medtronic. A. Musetto: Speaker fees from Olympus. J. Plervis: Speaker honorarium, study and travel support from Jinshan OMOM; advisory board, study and travel support from drFalk.
Publisher Copyright:
© 2023 American Society for Gastrointestinal Endoscopy
PY - 2023/5
Y1 - 2023/5
N2 - Background and Aims: Meckel's diverticulum (MD) may remain silent or be associated with adverse events such as GI bleeding. The main aim of this study was to evaluate indicative small-bowel capsule endoscopy (SBCE) findings, and the secondary aim was to describe clinical presentation in patients with MD. Methods: This retrospective European multicenter study included patients with MD undergoing SBCE from 2001 until July 2021. Results: Sixty-nine patients with a confirmed MD were included. Median age was 32 years with a male-to-female ratio of approximately 3:1. GI bleeding or iron-deficiency anemia was present in nearly all patients. Mean hemoglobin was 7.63 ± 1.8 g/dL with a transfusion requirement of 52.2%. Typical capsule endoscopy (CE) findings were double lumen (n = 49 [71%]), visible entrance into the MD (n = 49 [71%]), mucosal webs (n = 30 [43.5%]), and bulges (n = 19 [27.5%]). Two or more of these findings were seen in 48 patients (69.6%). Ulcers were detected in 52.2% of patients (n = 36). In 63.8% of patients (n = 44), a combination of double lumen and visible entrance into the MD was evident, additionally revealing ulcers in 39.1% (n = 27). Mean percent SB (small bowel) transit time for the first indicative image of MD was 57% of the total SB transit time. Conclusions: Diagnosis of MD is rare and sometimes challenging, and a preoperative criterion standard does not exist. In SBCE, the most frequent findings were double-lumen sign and visible diverticular entrance, sometimes together with ulcers.
AB - Background and Aims: Meckel's diverticulum (MD) may remain silent or be associated with adverse events such as GI bleeding. The main aim of this study was to evaluate indicative small-bowel capsule endoscopy (SBCE) findings, and the secondary aim was to describe clinical presentation in patients with MD. Methods: This retrospective European multicenter study included patients with MD undergoing SBCE from 2001 until July 2021. Results: Sixty-nine patients with a confirmed MD were included. Median age was 32 years with a male-to-female ratio of approximately 3:1. GI bleeding or iron-deficiency anemia was present in nearly all patients. Mean hemoglobin was 7.63 ± 1.8 g/dL with a transfusion requirement of 52.2%. Typical capsule endoscopy (CE) findings were double lumen (n = 49 [71%]), visible entrance into the MD (n = 49 [71%]), mucosal webs (n = 30 [43.5%]), and bulges (n = 19 [27.5%]). Two or more of these findings were seen in 48 patients (69.6%). Ulcers were detected in 52.2% of patients (n = 36). In 63.8% of patients (n = 44), a combination of double lumen and visible entrance into the MD was evident, additionally revealing ulcers in 39.1% (n = 27). Mean percent SB (small bowel) transit time for the first indicative image of MD was 57% of the total SB transit time. Conclusions: Diagnosis of MD is rare and sometimes challenging, and a preoperative criterion standard does not exist. In SBCE, the most frequent findings were double-lumen sign and visible diverticular entrance, sometimes together with ulcers.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150270355&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36572128
U2 - 10.1016/j.gie.2022.12.014
DO - 10.1016/j.gie.2022.12.014
M3 - Article
C2 - 36572128
SN - 0016-5107
VL - 97
SP - 917-926.e3
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 5
ER -